Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1994 4
1995 7
1996 8
1997 24
1998 25
1999 29
2000 40
2001 37
2002 51
2003 40
2004 68
2005 84
2006 81
2007 106
2008 105
2009 111
2010 102
2011 101
2012 99
2013 99
2014 103
2015 98
2016 86
2017 76
2018 92
2019 97
2020 114
2021 100
2022 84
2023 50

Text availability

Article attribute

Article type

Publication date

Search Results

1,897 results

Results by year

Filters applied: . Clear all
Page 1
Botulinum toxin type A and acupuncture for masticatory myofascial pain: a randomized clinical trial.
DE LA Torre Canales G, Câmara-Souza MB, Poluha RL, Grillo CM, Conti PCR, Sousa MDLR, Rodrigues Garcia RCM, Rizzatti-Barbosa CM. DE LA Torre Canales G, et al. J Appl Oral Sci. 2021 Jun 4;29:e20201035. doi: 10.1590/1678-7757-2020-1035. eCollection 2021. J Appl Oral Sci. 2021. PMID: 34105695 Free PMC article. Clinical Trial.
OBJECTIVE: this study aimed to compare the immediate effects of botulinum toxin type A (BoNT-A) injections and Acupuncture in myofascial temporomandibular disorders (TMD) patients. ...
OBJECTIVE: this study aimed to compare the immediate effects of botulinum toxin type A (BoNT-A) injections and Acupunct …
Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia.
Zhou Y, Yu S, Zhao J, Feng X, Zhang M, Zhao Z. Zhou Y, et al. Biomed Res Int. 2020 Aug 4;2020:1501893. doi: 10.1155/2020/1501893. eCollection 2020. Biomed Res Int. 2020. PMID: 32802833 Free PMC article. Clinical Trial.
Therefore, the present study is aimed at investigating the efficacy and safety of botulinum toxin type A (BTA) in patients with AGA. METHODS: 63 patients with AGA meeting the inclusion criteria were included in this study and treated with BTA injection or BTA …
Therefore, the present study is aimed at investigating the efficacy and safety of botulinum toxin type A (BTA) in patie …
Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
Jadhao VA, Lokhande N, Habbu SG, Sewane S, Dongare S, Goyal N. Jadhao VA, et al. Indian J Dent Res. 2017 Sep-Oct;28(5):493-497. doi: 10.4103/ijdr.IJDR_125_17. Indian J Dent Res. 2017. PMID: 29072209 Free article. Clinical Trial.
AIM AND OBJECTIVE: The present study was conducted in patients with bruxism to evaluate the effect of botulinum toxin type A (BTX-A) (Botox, Allergan, Inc., Irvine, CA, USA) in the treatment of myofascial pain and the occlusal force characteristics of mastica …
AIM AND OBJECTIVE: The present study was conducted in patients with bruxism to evaluate the effect of botulinum toxin type …
Intra-articular botulinum toxin type A for treatment of knee osteoarthritis: Clinical trial.
Najafi S, Sanati E, Khademi M, Abdorrazaghi F, Mofrad RK, Rezasoltani Z. Najafi S, et al. Toxicon. 2019 Jul;165:69-77. doi: 10.1016/j.toxicon.2019.04.003. Epub 2019 Apr 14. Toxicon. 2019. PMID: 30995453 Clinical Trial.
In recent years, there is a growing interest in new medical applications of botulinum toxin, including pain control, osteoarthritis treatment, and wound healing. While clinical applications of botulinum toxin seem promising, existing evidence regarding …
In recent years, there is a growing interest in new medical applications of botulinum toxin, including pain control, osteoarth …
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature.
Campanati A, Martina E, Gregoriou S, Kontochristopoulos G, Paolinelli M, Diotallevi F, Radi G, Bobyr I, Marconi B, Gualdi G, Amerio P, Offidani A. Campanati A, et al. Toxins (Basel). 2022 May 27;14(6):372. doi: 10.3390/toxins14060372. Toxins (Basel). 2022. PMID: 35737033 Free PMC article. Clinical Trial.
Among the forms of idiopathic hyperhidrosis, those involving the forehead have the greatest impact on patients' quality of life, as symptoms are not very controllable and are difficult to mask for patients. Although the local injection therapy with Incobotulinum toxin t …
Among the forms of idiopathic hyperhidrosis, those involving the forehead have the greatest impact on patients' quality of life, as symptoms …
DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2).
Carruthers JD, Fagien S, Joseph JH, Humphrey SD, Biesman BS, Gallagher CJ, Liu Y, Rubio RG; SAKURA 1 and SAKURA 2 Investigator Group; SAKURA 1 and SAKURA 2 Investigator Group includes the following. Carruthers JD, et al. Plast Reconstr Surg. 2020 Jan;145(1):45-58. doi: 10.1097/PRS.0000000000006327. Plast Reconstr Surg. 2020. PMID: 31609882 Free PMC article. Clinical Trial.
BACKGROUND: DaxibotulinumtoxinA for Injection (DAXI) is a novel botulinum toxin type A formulation in clinical development. A phase 2 dose-ranging study identified an optimal dose and demonstrated efficacy with a median duration of 24 weeks. ...
BACKGROUND: DaxibotulinumtoxinA for Injection (DAXI) is a novel botulinum toxin type A formulation in clinical developm …
Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial.
Wollmer MA, Neumann I, Jung S, Bechinie A, Herrmann J, Müller A, Wohlmuth P, Fournier-Kaiser L, Sperling C, Peters L, Kneer J, Engel J, Jürgensen F, Schulze J, Nagel M, Prager W, Sinke C, Kahl KG, Karst M, Dulz B, Kruger THC. Wollmer MA, et al. J Psychopharmacol. 2022 Feb;36(2):159-169. doi: 10.1177/02698811211069108. Epub 2022 Feb 1. J Psychopharmacol. 2022. PMID: 35102782 Clinical Trial.
BACKGROUND: Inhibition of frowning via injections of botulinum toxin A (BTX) into the glabellar region has shown beneficial effects in the treatment of major depression. ...CONCLUSION: Evidence regarding the efficacy of BTX for BDP remains limited, and the design of …
BACKGROUND: Inhibition of frowning via injections of botulinum toxin A (BTX) into the glabellar region has shown beneficial ef …
Effects of Two Botulinum Toxin Type a Evaluated by Shear Wave Elastography and Electromyographic Measurements of Masseter Reduction.
Guo Y, Diao X, Dong D, Xia W, Liu T, Zhou Y, Zhu J, Chen L, Chen Y. Guo Y, et al. J Craniofac Surg. 2022 Jul-Aug 01;33(5):1450-1453. doi: 10.1097/SCS.0000000000008368. Epub 2022 Jun 27. J Craniofac Surg. 2022. PMID: 35758504 Clinical Trial.
The purpose of this study was to evaluate the efficacy and safety of onabotulinumtoxin A and Chinese botulinum toxin type A (CBA) for masseter reduction using elastography and electromyographic measurement. ...
The purpose of this study was to evaluate the efficacy and safety of onabotulinumtoxin A and Chinese botulinum toxin type …
Subcutaneous botulinum toxin type A injections for provoked vestibulodynia: a randomized placebo-controlled trial and exploratory subanalysis.
Diomande I, Gabriel N, Kashiwagi M, Ghisu GP, Welter J, Fink D, Fehr MK, Betschart C. Diomande I, et al. Arch Gynecol Obstet. 2019 Apr;299(4):993-1000. doi: 10.1007/s00404-019-05043-w. Epub 2019 Feb 1. Arch Gynecol Obstet. 2019. PMID: 30707361 Clinical Trial.
BACKGROUND: Previous studies using botulinum toxin type A (BT) to treat provoked vestibulodynia (PVD) reported conflicting findings, possibly attributable to singular injections or low doses. ...
BACKGROUND: Previous studies using botulinum toxin type A (BT) to treat provoked vestibulodynia (PVD) reported conflict …
1,897 results